Determinants of response to daratumumab in Epstein-Barr virus-positive natural killer and T-cell lymphoma

• المؤلفون الرئيسيون: Mustafa, Nurulhuda, Nee, Adina Huey Fang, Chooi, Jing Yuan, Toh, Sabrina Hui Min, Chung, Tae-Hoon, Selvarajan, Viknesvaran, Fan, Shuangyi, Ng, Siok Bian, Poon, Michelle, Chan, Esther, Lee, Joanne, Chee, Yen Lin, Jeyasekharan, Anand D, Zhou, Longen, Yang, Jennifer, Chng, Wee Joo
• مؤلفون آخرون: MEDICINE
• التنسيق: مقال
• اللغة: English
• منشور في: BMJ PUBLISHING GROUP 2021
• الموضوعات: Science & Technology; Life Sciences & Biomedicine; Oncology; Immunology; antibodies; neoplasm; drug evaluation; preclinical; hematologic neoplasms; immunotherapy; MEMBRANE COFACTOR PROTEIN; DECAY-ACCELERATING FACTOR; MULTIPLE-MYELOMA; CD38 EXPRESSION; NASAL TYPE; COMPLEMENT REGULATORS; ANTITUMOR-ACTIVITY; HEMATOPOIETIC SCT; TARGETING CD38; ANTIBODY
• الوصول للمادة أونلاين: https://scholarbank.nus.edu.sg/handle/10635/206598

10.1136/jitc-2020-002123